Stephen T. Worland
2021
In 2021, Stephen T. Worland earned a total compensation of $3.4M as President and Chief Executive Officer at eFFECTOR Therapeutics, a 428% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $220,000 |
|---|---|
| Salary | $501,442 |
| Stock Awards | $2,652,658 |
| Other | $31,952 |
| Total | $3,406,052 |
Worland received $2.7M in stock awards, accounting for 78% of the total pay in 2021.
Worland also received $220K in non-equity incentive plan, $501.4K in salary and $32K in other compensation.
Rankings
In 2021, Stephen T. Worland's compensation ranked 3,927th out of 12,406 executives tracked by ExecPay. In other words, Worland earned more than 68.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,927 out of 12,406 | 68th |
Division Manufacturing | 1,609 out of 5,492 | 71st |
Major group Chemicals And Allied Products | 662 out of 2,368 | 72nd |
Industry group Drugs | 587 out of 2,089 | 72nd |
Industry Pharmaceutical Preparations | 409 out of 1,536 | 73rd |
Source: SEC filing on April 20, 2022.
Worland's colleagues
We found three more compensation records of executives who worked with Stephen T. Worland at eFFECTOR Therapeutics in 2021.